Peter I. Jatlow, MD, former professor and chair of the Department of Laboratory Medicine, died at age 84 on May 18, 2020, after a long illness. He was recognized as an extraordinary leader and educator and was the recipient of many scientific awards.
Jatlow was born in New Brunswick, New Jersey, and grew up in Mount Vernon, New York. He received his BS from Union College in 1957 and his MD in 1961 from the State University of New York, Downstate Medical Center. After a mixed medicine-surgery internship at Montefiore Hospital in Bronx, New York, he spent four years as a resident and postdoctoral trainee in laboratory medicine and pathology at Yale School of Medicine and Yale New Haven Hospital, under the leadership of David Seligson, first chair of Yale Laboratory Medicine, and Averill Liebow. From 1966 to 1968, Jatlow was in the U.S. Public Health Service, where he set up the first pathology and laboratory medicine department for the Alaskan Native Medical Center in Anchorage, Alaska. He returned to New Haven to join the faculty at Yale as assistant professor of Laboratory Medicine in 1968 and rose through the academic ranks to reach full professor in 1976. He was director of the Yale New Haven Hospital Clinical Chemistry Laboratory from 1975 through 1984. In that year, upon Dr. Seligson's retirement, he became chair and chief of the department and remained in that position until he decided to step down in academic 2006-07. Dr. Jatlow returned to his NIH-funded research laboratory, teaching, and working as a clinical chemist, continuing his investigations in nicotine and alcohol addiction through to the present year.
Jatlow received many awards, including the coveted Cotlove Award from the Academy of Clinical Laboratory Physicians and Scientists. Recipients of the Cotlove have included two subsequent Nobel Prize winners and five subsequent Lasker awardees. He also was honored for outstanding contributions to research recognition from the American Association for Clinical Chemistry, received the Irving Sunshine Award in Clinical Toxicology of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, and was elected as a Fellow of the AAAS for "Research and Leadership in Laboratory Medicine." He published more 240 original articles, mostly in the area of the pharmacology of psychotropic drugs and co-edited The Yale University School of Medicine Patient's Guide To Medical Tests with Yale faculty members Drs. Barry Zaret and Lee Katz. With colleagues in the Department of Psychiatry he reported some of the first studies of the human pharmacokinetics and dynamics of cocaine and its active ethanol derived metabolite cocaethylene.
While his major contributions to both the field and to the School will continue to benefit future generations of laboratorians and pathologists, as well as those engaged in seeking the biological basis of addiction, his always insightful and encyclopedic commentary, wry wit, and deep affection for the training of the next generations of physicians, scientists, and physician-scientists, will be sorely missed.
Dr. Jatlow was born in New Brunswick, New Jersey and grew up in Mount Vernon, New York. He received his BS from Union College in 1957 and his MD in 1961 from the State University of New York, Downstate Medical Center. After a mixed medicine-surgery internship at Montefiore Hospital in Bronx, New York, Dr. Jatlow spent four years as a resident and postdoctoral trainee in laboratory medicine and pathology at Yale School of Medicine and Yale New Haven Hospital, under the leadership of David Seligson, first chair of Yale Laboratory Medicine, and Averill Liebow. From 1966 to 1968, Dr. Jatlow was in the U.S. Public Health Service, where he set up the first pathology and laboratory medicine department for the Alaskan Native Medical Center in Anchorage, Alaska. He returned to New Haven to join the faculty at Yale as assistant professor of Laboratory Medicine in 1968 and rose through the academic ranks to reach full professor in 1976. He was director of the Yale New Haven Hospital Clinical Chemistry Laboratory from 1975 through 1984. In that year, upon Dr. Seligson's retirement, he became chair and chief of the department and remained in that position until he decided to step down in academic 2006-07. Dr. Jatlow returned to his NIH-funded research laboratory, teaching, and working as a clinical chemist, continuing his investigations in nicotine and alcohol addiction through to the present year.
Peter Jatlow provided truly extraordinary leadership to the Department of Laboratory Medicine over the 22 years of his tenure as chair and chief. The department grew dramatically in research presence, clinical scope, and teaching contributions. Total grant dollars increased over six-fold; the department added NIH Center Grants and T32 training programs to its portfolio. On the clinical laboratory front, test volume increased nearly 10-fold. Moreover, programs in stem cell collection, processing, and engineering were added (including an Advanced Cell Therapy Laboratory), as were major efforts in molecular diagnostics, flow cytometry, and other state-of-the-art, leading edge technologies. From the educational perspective, the department took on responsibility for the second year medical student microbiology course in addition to medical student laboratory medicine instruction. Laboratory medicine faculty recruited by Dr. Jatlow have won the Basic Science Bohmfalk teaching award five times, attesting to the excellence of that endeavor. In addition, fellowship programs were added in microbiology, hematopathology and transfusion medicine.
Although always modest with respect to his own research and clinical contributions to the department, Peter Jatlow is the recipient of many awards, including the coveted Cotlove Award from the Academy of Clinical Laboratory Physicians and Scientists. The recipients of the Cotlove have included two subsequent Nobel Prize winners and five subsequent Lasker awardees. In addition, he garnered many major awards in his field, including an outstanding contributions to research recognition from the American Association for Clinical Chemistry, the Irving Sunshine Award in Clinical Toxicology of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, and election to Fellow of the AAAS for "Research and Leadership in Laboratory Medicine." He published over 240 original articles, mostly in the area of the pharmacology of psychotropic drugs and co-edited with Yale faculty members, Drs. Barry Zaret and Lee Katz, The Yale University School of Medicine Patient's Guide To Medical Tests. With colleagues in the Department of Psychiatry he reported some of the first studies of the human pharmacokinetics and dynamics of cocaine and its active ethanol derived metabolite cocaethylene.
He is survived by his wife, Stephanie, and two daughters, Allison Beitler and Julie Guilmette, two sons-in-law, Richard and Keith, and by his three grandsons, Gordon, Brian, and Daniel.